Fyrwald J Erik, CEO of an undisclosed company, has demonstrated a consistent buying pattern across two major firms—Eli Lilly (LLY) and International Flavors & Fragrances (IFF)—with no recorded sales in his 27 reported transactions. His total acquisitions amount to $5.62 million, with the bulk of activity concentrated in IFF through private placements (code "P"), including a $2.01 million purchase on March 4, 2025, and a $933,224 transaction on March 13, 2026. LLY transactions, primarily coded as open-market acquisitions (code "A"), show smaller, recurring buys averaging around $9,916 per trade, with notable exceptions like two $219,999 purchases in November 2025. The most recent activity includes dual LLY acquisitions on March 16, 2026, each valued at $9,916.92, reinforcing a steady accumulation strategy.
The data reveals a clear directional bias: Fyrwald has not sold any shares in either company since at least February 2025. His IFF investments, though less frequent, involve significantly larger sums compared to the smaller, more routine LLY buys. The absence of sales suggests a long-term holding strategy, particularly in IFF, where private placements indicate direct participation in equity offerings. The pattern is notable for its discipline—small, periodic LLY purchases alongside selective, high-value IFF investments—without any divestment activity over the observed period.
AI-assisted summary